3D-NET

 

Drug Discovery

and Development of

Novel Eye Therapeutics

 

There is an unmet clinical need for more effective treatments to halt or reverse eye diseases that lead to blindness (like age-related macular degeneration, diabetic retinopathy, and corneal inflammation) with increasing prevalence as the EU population ages.

 

3D-NET establishes a European network of industry and academic partners, who exchange knowledge, people, and expertise to enhance the discovery and development of drugs that target these ocular pathologies (Funded by a FP7- Marie Curie IAPP grant).

 

     PARTNERS AND OBJECTIVES

     BACKGROUND

     WORK PACKAGES

     FELLOWS

     EXTERNAL ADVISORY BOARDS

     NEWS AND JOB VACANCIES

*3DNET WORKSHOP ON DRUG DISCOVERY AND OCULAR THERAPY (VALLADOLID 23-09-2014)

     LINKS OF INTEREST

     CONTACT

 


Follow Us on Facebook, Twitter and LinkedIn

 

Marie Curie Industry-Academia Partnerships and Pathways (IAPP)

Project Number (612218/3D-NET)